It has been discovered that daphnetin, when used to treat various malignancies, blocks melanogenesis in B16F10 melanoma cells caused by α-melanocyte stimulating hormone (α-MSH) by inhibiting the PKA and ERK signaling pathways [16]. This evidence concerns the gene STAMBP and melanoma.